3 High Upside Stocks Under $10

Last week, the S&P lost 2.52% in value. Oil prices, while more stable than in prior weeks, remain elevated, and the same holds true for the VIX, a measure of expected volatility.

There is also a brewing disconnect in terms of sentiment. JP Morgan cut its S&P 500 target for 2026 from 7,500 to 7,200, and now forecasts that the benchmark index could see a slide to levels as low as 6,000 if current headwinds continue. At the same time, in the shorter term, overall consensus among analysts is that companies in the index will post double-digit earnings growth for the sixth quarter in a row in Q1 2026, around the 12.5% mark.

There are no easy trades on the board. Energy and its sympathy plays have already rallied, and the rest of the stock market is both volatile and generally in the red.

Making the most of circumstances like these requires an edge — and not an abstract one at that, but something quantifiable and proven. You can secure such an edge for yourself — by making use of ….

Under $10 Stock Strategy

Our proprietary quant rating system evaluates 4,600 stocks every single day through the lens of 115 unique metrics and factors, split across 7 categories. This provides a deep, balanced overview of a stock’s fundamentals, and it’s all distilled into a single, easy to use metric — a stock’s Zen Rating.

Only the stocks that score in the top 5% are given a Zen Rating of A, equivalent to a Strong Buy rating. That’s a great start, but it does still leave you with about 230 stocks to look into on any given day.

However, you can narrow the search down even further — by taking a look at one of our exclusive Zen Strategies.

These are 11 meticulously-crafted stock portfolios, each consisting of just 7 tickers selected to deliver outsized returns. Today, we’ll be taking a look at one of our top-performing portfolios of 2026. 

Despite the market downturn, it has provided a 22.4% return since the start of the year — and it’s also managed to secure a 2.82% gain in the past 30 days, while the S&P 500 slipped by 4.84% in the same timeframe. Without further ado, let’s dig into 3 interesting tickers from our Under $10 Stock Strategy.

Embecta (EMBC)

Our first pick, Embecta, is a medical device company focusing on diabetes treatment. EMBC currently ranks in the top 2% of stocks, giving it a Zen Rating of A, and it’s the 2nd highest-rated stock in the Medical industry, which has an Industry Rating of B.

The business delivered an earnings beat on February 5 — its 13th in a row. However, profit taking and recent market dynamics have caused Embecta shares to lose 12% in value since that quarterly report. The opportunity is in buying the dip, since the fundamentals haven’t deteriorated.

For one, we have a fortress balance sheet — EMBC ranks in the 97th percentile for Financials. Then, we have an incredibly appealing valuation; thanks to a price-to-earnings growth (PEG) ratio of 0.45x, Embecta is in the top 1% of stocks in terms of the Component Grade rating. It also has a B rating for Growth, and ranks in the 74th percentile in that category. Lastly, when it comes to our Artificial Intelligence rating, which uses a neural network trained on more than two decades of market data, Embecta ranks in the top 4%.

It’s cheap, the growth prospects are solid, there’s a solid track record in terms of execution, and the business has a strong financial position that can allow it to weather downturns. The downside are low scores for Momentum and Safety, but those are easily overshadowed by EMBC’s strengths, particularly when looking at it as a long-term holding. Lastly, that dip could reverse soon — EMBC closed in the green last week after news of a $200 million acquisition, so an improvement on the Momentum front isn’t out of the question.

Auna SA (AUNA)

Auna SA operates hospitals, clinics, and insurance platforms in Latin America. AUNA shares currently rank in the top 2% of the equities we track, and they rank 3rd overall in the Medical Care Facility industry, which has an Industry Rating of A.

The thing that jumps out most at you from the page is the one-two punch of high ratings for both Growth and Value. In terms of the former, it ranks in the top 5% — when it comes to the latter, it ranks in the top 1%. That’s really the core of the thesis here — solid growth prospects, plus 4 consecutive earnings beats, and a price-to-earnings (P/E) ratio of just 14.65x.

AUNA also carries a strong B rating for Sentiment, where it ranks in the 92nd percentile of stocks. In January, Jefferies set a $9 price target for the stock, which implies an upside of more than 30% from current levels.

The drawbacks here are a weak Momentum rating and an average (63rd percentile) rating for Financials. However, there’s been solid improvement when it comes to Momentum — after the last earnings beat on March 10, the stock has rallied by a little over 20%, so the wisest course of action might very well be to lock in the existing discount before it disappears.

Galiano Gold (GAU)

Our last pick for this week is Galiano Gold, a gold producer with operations concentrated in Ghana. Like our previous picks, it ranks in the top 2% for fundamentals across the board, and it’s also the 6th highest-rated stock in the Gold industry, which has an Industry Rating of A.

The Artificial Intelligence rating is a strong point here. GAU has a strong B grade in this category, where it ranks in the top 9% of stocks. To boot, it also offers a compelling mix of Value and Growth — categories where it ranks in the 93rd and 95th percentile, respectively.

This is the riskiest pick on the list. The stock has a low Safety score, and it isn’t profitable yet. However, if you have the risk appetite, it might be worth a shot. There have been several promising signs tied to this ticker as of late. 

Galiano Gold beat EPS estimates by 50% in its latest quarterly report in early February. The stock was also recently included in the VanEck Junior Gold Miners ETF (GDXJ). Finally, production increased by roughly 80% in 2025, so the growth trajectory isn’t just conjecture.

Top 2%

With GAU, the question boils down to your stance on gold. If it is bullish, this underappreciated turnaround story could offer early-stage upside before the broader market catches on.

Interested In More Great Stock Picks? 

The 3 stocks highlighted above are just a fraction of what you get from our proven Under $10 Stock Strategy.

That’s because each day our system recalibrates — and Zen Strategies members get access to the top 7 value stocks based on 115 different parameters that point to outperformance. 

See all Top 7 Under $10 Stocks here >

However, maybe none of the stocks you’ve seen here have caught your eye. Perhaps you would like to see all 11 of our market beating strategies including Growth, Momentum, Technology, and our coveted AI Factor model. 

Each featuring the top 7 stocks.

Each featuring tremendous performance

We spell it all out in this timely presentation below that lives up to its name:

10 Minutes a Month to Beat the Market > 

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.